Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 587

1.

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.

Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ.

Br J Surg. 2003 Apr;90(4):426-32.

PMID:
12673743
2.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
3.

An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.

MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R, Wazer DE.

Cancer. 2007 Dec 15;110(12):2648-53.

4.

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.

Altintas S, Lambein K, Huizing MT, Braems G, Asjoe FT, Hellemans H, Van Marck E, Weyler J, Praet M, Van den Broecke R, Vermorken JB, Tjalma WA.

Breast J. 2009 Mar-Apr;15(2):120-32. doi: 10.1111/j.1524-4741.2009.00686.x.

PMID:
19292797
5.

A prognostic index for ductal carcinoma in situ of the breast.

Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN.

Cancer. 1996 Jun 1;77(11):2267-74.

6.

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.

Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.

Cancer. 2004 Jun 1;100(11):2317-27.

7.

Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.

Van Zee KJ, Liberman L, Samli B, Tran KN, McCormick B, Petrek JA, Rosen PP, Borgen PI.

Cancer. 1999 Nov 1;86(9):1757-67.

PMID:
10547549
8.

Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.

de Mascarel I, Bonichon F, MacGrogan G, de Lara CT, Avril A, Picot V, Durand M, Mauriac L, Trojani M, Coindre JM.

Breast Cancer Res Treat. 2000 May;61(2):151-9.

PMID:
10942101
9.
10.

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5.

PMID:
12459354
11.
12.

Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.

Kelley L, Silverstein M, Guerra L.

Ann Surg Oncol. 2011 Feb;18(2):459-62. doi: 10.1245/s10434-010-1335-2. Epub 2010 Sep 22.

PMID:
20859695
13.

[Margin status in ductal carcinoma in situ of the breast].

Vincens E, Alves K, Lauratet B, Cohen S, Bakenga J, Trie A, Lefranc JP.

Bull Cancer. 2008 Dec;95(12):1155-9. doi: 10.1684/bdc.2008.0759. Review. French.

14.

The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.

Asjoe FT, Altintas S, Huizing MT, Colpaert C, Marck EV, Vermorken JB, Tjalma WA.

Breast J. 2007 Jul-Aug;13(4):359-67.

PMID:
17593040
15.

Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).

Altintas S, Toussaint J, Durbecq V, Lambein K, Huizing MT, Larsimont D, Van Marck E, Vermorken JB, Tjalma WA, Sotiriou C.

Breast J. 2011 Jul-Aug;17(4):343-51. doi: 10.1111/j.1524-4741.2011.01091.x. Epub 2011 Jun 6.

PMID:
21645166
16.

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.

Holland PA, Gandhi A, Knox WF, Wilson M, Baildam AD, Bundred NJ.

Br J Cancer. 1998;77(1):110-4.

17.

Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.

Am J Surg. 2006 Oct;192(4):427-33.

PMID:
16978943
18.

Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.

Schouten van der Velden AP, Peeters PH, Koot VC, Hennipman A.

Ann Surg Oncol. 2006 Jul;13(7):990-8. Epub 2006 May 22.

PMID:
16788762
19.

The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.

Gilleard O, Goodman A, Cooper M, Davies M, Dunn J.

World J Surg Oncol. 2008 Jun 18;6:61. doi: 10.1186/1477-7819-6-61.

20.

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8. doi: 10.1111/j.1445-2197.2007.04354.x.

PMID:
18199204

Supplemental Content

Support Center